Multimedia
Overview
Accommodations
Opportunities
Abstract Submissions
Faculty
Registration

Accreditation/
Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC designates this live activity for a maximum of 22.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669 for 22.0 Contact Hours.

Acknowledgment of Commercial Support

This activity is supported by an educational grants from AbbVie, AstraZeneca, BeyondSpring Pharmaceuticals, Inc., Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb, Celgene Corporation, Genentech, Lilly, Merck Sharp & Dohme Corp, Novartis Pharmaceuticals Corporation, and Takeda Oncology.

For further information concerning Lilly grant funding visit www.lillygrantoffice.com.

18th Annual International Lung Cancer Congress®

18th Annual International Lung Cancer Congress®


July 27 - 29, 2017
Hyatt Regency Huntington Beach
21500 Pacific Coast Highway
Huntington Beach, CA
Reservation: (888) 421-1442


Overview

The 18th Annual International Lung Cancer Congress® will provide current, practical information on the management of lung cancer, as well as a look at the novel agents and strategies with the potential to shape the future of lung cancer therapy. Leading international and national experts will address critical topics in lung cancer screening, personalized therapy, and the latest clinical data impacting the treatment of lung cancer. Cutting-edge lectures, panel discussions, multidisciplinary tumor boards, and interactive question-and-answer sessions will provide a unique opportunity for participants to engage with faculty as they share their perspectives and personal experiences on the clinical challenges and ongoing controversies in lung cancer management. The meeting will continue the tradition of highlighting the clinical research activity of Cooperative Groups in the United States, Europe, and Asia.

Acknowledgment of Commercial Support

This activity is supported by an educational grants from AbbVie, AstraZeneca, BeyondSpring Pharmaceuticals, Inc., Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb, Celgene Corporation, Genentech, Lilly, Merck Sharp & Dohme Corp, Novartis Pharmaceuticals Corporation, and Takeda Oncology.

For further information concerning Lilly grant funding visit www.lillygrantoffice.com.


Target Audience

This educational activity is directed toward medical, surgical and radiation oncologists interested in the treatment of patients with lung cancer. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers and other healthcare professionals interested in the treatment of lung cancer are also invited to attend.


Learning Objectices

  • Delineate testing strategies for the diagnosis and identification of biomarkers which can be used to facilitate clinical decision-making in multiple lines of lung cancer care
  • Explain evolving treatment strategies for early-stage and locally advanced lung cancer
  • Determine optimized sequencing strategies for the management of advanced lung cancer based on clinical data sets, performance status, and tumor characteristics
  • Assess current data sets and ongoing clinical trials evaluating single agent and combination immunotherapeutic approaches
  • Place recent clinical trial results on chemotherapeutic, targeted, and immunotherapeutic strategies in the context of current treatment standards and evolving paradigms in the management of lung cancer
  • Explain the current status of cooperative group trials and methods to facilitate participation in clinical trials that are assessing emerging strategies to treat lung cancer


Program Directors

David R. Gandara, MD
Professor of Medicine
Division of Hematology/Oncology
Director, Thoracic Oncology Program
Senior Advisor to the Director
UC Davis Comprehensive Cancer Center
Sacramento, CA


Roy S. Herbst, MD, PhD
Ensign Professor of Medicine (Medical Oncology)
Professor of Pharmacology
Chief of Medical Oncology
Associate Director for Translational Research
Yale Cancer Center
Yale School of Medicine
New Haven, CT




Register

You must be logged in to PER to register for this meeting

Or Register for PER now

*Required Fields

Login Information


Registration Information


In case of onsite emergency:

Professional Information


Specialties*

Assumption of Risk and Waiver of Liability Relating to Coronavirus/COVID-19

I understand that the hazards of the novel coronavirus ("COVID-19") and have reviewed the Centers for Disease Control and Prevention ("CDC") current guidelines in regards to COVID-19. I acknowledge that while Physicians' Education Resource, LLC ("PER") ("Company") has put in place preventative measures to reduce the spread of COVID-19, Company cannot guarantee that I or anyone else will not become infected with COVID-19. I attest that if within the fourteen (14) days prior to the event, I am experiencing any symptoms of COVID-19, or I have been in close contact with anyone that has been diagnosed with COVID-19, then I will not attend the Activities. I shall follow any safety, social distancing, masking, and hygiene protocols that have been implemented at the Activities.

I hereby willingly and voluntarily choose to attend this PER event and related activities ("Activity"). I acknowledge and fully assume the risk and hazards of exposure to COVID-19 and that such exposure or infection may result in personal injury, illness, permanent disability, and death to myself, my spouse, children, unborn child, or relatives. I hereby release covenant not to sue, forever discharge, and hold harmless Company and its affiliates from all liability claims and demands of whatever kind of nature, either in law or in equity, which arise or may hereafter arise from participating in the Activities. I assume all risks of losses, damages, or injuries that may be sustained while participating in the Activity. I understand and agree that this release includes any Claims based on the actions, omissions, or negligence of the venue, employees, vendors, agents, and representatives, whether a COVID-19 infection occurs before, during, or after participation in the Activity.

* By checking this box, you have read and understand the above and agree to its terms.

Submit
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
     12
3456789
10111213141516
17181920212223
24252627282930
31
Filter By